Economist: Essential Drug "Zero-slip" Policy Will Bring Big Problems
This article was originally published in PharmAsia News
Executive Summary
Health personnel in Zhejiang province expressed doubts about the zero-slip policy and the potentially negative effects it would bring. Community health service institution revenue comes from three sources: drug sales, medical services and financial subsidies. In the majority of institutions, drug sales account for more than 70 percent of total revenue. The zero-slip policy will greatly reduce income from drug sales, creating a RMB 90 million budget gap for Haining city, which is only offering RMB 5 million in compensation. A doubling of medical service prices would not even make up for half of the budget gap. Some fear that staff reductions may be the only means to maintain balance. (Click Here For More - Chinese Language
You may also be interested in...
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.
Helping Organizations Deliver On KPIs And Giving Staff A Voice
ImproveWell has won awards for its software technology that allows health care staff at the sharp end of patient care to report on problems as they happen. The outcome is a real-time learning process that contributes to improved operational efficiencies for health systems, says In Vivo Rising Leader Lara Mott.
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.